Mounjaro vs Zepbound
Last updated
These brands contain tirzepatide. Compare their approved uses, formulations, and self-pay prices. Products are not interchangeable.
Mounjaro vs Zepbound: the lowest prices now



Zepbound KwikPen: the lowest price at a seller we link to
$549.99/mo · $269 more per 30 days than LillyDirect (Eli Lilly)

| Compare | Mounjaro | Zepbound |
|---|---|---|
| Active ingredient | TirzepatideGIP/GLP-1 | TirzepatideGIP/GLP-1 |
| How it is taken | Injection Once weekly | Injection Once weekly |
| Manufacturer | Eli Lilly | Eli Lilly |
What was actually compared
No direct trial comparing these exact brands is included in our reviewed catalog. Sharing an ingredient does not establish the same outcomes at different doses or formulations.
Weight-loss results by formulation
Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.
| Compare | Mounjaro | Zepbound |
|---|---|---|
| Injection evidence | No reviewed weight-loss result for this brand and formulation. | −20.9% (nejm.org/doi/full/10.1056/NEJMoa2206038) (-20.9% at 72 wks · SURMOUNT-1 · 15 mg weekly (Zepbound)) SURMOUNT-1 · -20.9% at 72 wks (nejm.org) 15 mg weekly (Zepbound) Accounts for treatment discontinuation |
Entry price and maintenance price
Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.
| Compare | Mounjaro | Zepbound |
|---|---|---|
| Injection prices | Advertised entry price from $499/28 days (lilly.com/lillydirect/mounjaro)28-day supply (lilly.com) ≈ $534.64 per 30 days at this quoted rate Checked on lilly.com Mounjaro single-dose pens
self-pay, four weekly pens; published starting rate at each dose Price conditionsself-pay, four weekly pens; published starting rate at each dose The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days. 28-day supply Published maintenance dose from $499/28 days (lilly.com/lillydirect/mounjaro)28-day supply (lilly.com) ≈ $534.64 per 30 days at this quoted rate Checked on lilly.com At 15 mg Mounjaro single-dose pens
Published price at 15 mg Price conditionsPublished price at 15 mg The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days. The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply. 28-day supply | Advertised entry price $299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)28-day supply (zepbound.lilly.com) ≈ $320.36 per 30 days at this quoted rate Checked on zepbound.lilly.com Zepbound KwikPen (multi-dose pen)
self-pay cash, by dose ($299 / $399 / $449) Price conditionsself-pay cash, by dose ($299 / $399 / $449) Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days. 28-day supply Published maintenance dose $449/28 days (zepbound.lilly.com/hcp/coverage-savings)28-day supply (zepbound.lilly.com) ≈ $481.07 per 30 days at this quoted rate Checked on zepbound.lilly.com At 15 mg Zepbound KwikPen (multi-dose pen)
Published price at 15 mg Price conditionsPublished price at 15 mg Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days. Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg). 28-day supply |
How these quotes are selected
For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.
Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology
Mounjaro vs Zepbound side effects
Rate on the medicine, with the placebo rate in brackets, at the highest dose in each label's table. These come from separate trials, so they are not a head-to-head comparison.
| Side effect | Mounjaro 15 mg | Zepbound 15 mg |
|---|---|---|
| Nausea | 18% (4%) | 28% (8%) |
| Diarrhea | 17% (9%) | 23% (8%) |
| Vomiting | 9% (2%) | 13% (2%) |
| Constipation | 7% (1%) | 11% (5%) |
| Abdominal pain | 5% (4%) | 10% (5%) |
| Indigestion | 5% (3%) | 10% (4%) |
| Decreased appetite | 11% (1%) | not in table |
| Fatigue | not in table | 7% (3%) |
| Dizziness | not in table | 4% (2%) |
| Injection site reactions | not in table | 8% (2%) |
| Burping | not in table | 5% (1%) |
| Reflux | not in table | 5% (2%) |
| Gas | not in table | 4% (2%) |
| Bloating | not in table | 4% (2%) |
| Hair loss | not in table | 5% (1%) |
Mounjaro vs Zepbound: timing, generics and coverage
Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.
| Brand | Soonest top dose | Half-life | Generic approved? | Patent on the medicine to | On Medicare Part D, 2025 |
|---|---|---|---|---|---|
| Mounjaro | 15 mg from week 21 | about 5 days | No | Jun 14, 2039 | 1,592,517 |
| Zepbound | 15 mg from week 21 | about 5-6 days | No | May 13, 2036 | 160,298 |
How long each takes · Generics and patents · Who covers what
Approved uses by formulation
Eligibility, contraindications, and warnings are in each product's full prescribing information.
| Compare | Mounjaro | Zepbound |
|---|---|---|
| Injection | Glucose control in adults and children 10+ with type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes at high cardiovascular risk. US prescribing information (pi.lilly.com) (Mounjaro Injection prescribing information)Reviewed Nov 4, 2026 | Weight management in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity. US prescribing information (pi.lilly.com) (Zepbound Injection prescribing information)Reviewed Nov 4, 2026 |
Full evidence and safety information
What changed for Mounjaro and Zepbound
- PriceProtocol MD: Compounded tirzepatide via Protocol MD now $299/mo (was $319/mo) (read on protocolmd.com)
- PriceCorrected: Telezen MD, Compounded tirzepatide via Telezen MD, $228/mo on its own page (we had from $159/mo) (read on telezenmd.com)
- PriceCorrected: Ascend Vitality, Compounded tirzepatide via Ascend Vitality, $199/mo on its own page (we had from $119/mo) (read on av-life.com)
- PriceNexLife: Microdose tirzepatide via NexLife now $129/mo (was $159/mo) (read on nexlife.com)
- PriceRow Telehealth: Compounded tirzepatide via Row Telehealth now $249/mo (was from $249/mo) (read on rowtelehealth.com)
- PriceRow Telehealth: Compounded tirzepatide dissolving tablets (ODT) via Row Telehealth now $229/mo (was from $229/mo) (read on rowtelehealth.com)
Written from each source's own record as it changes. Every change on GLPcompare
Mounjaro vs Zepbound: common questions
Is Mounjaro the same as Zepbound?
They contain the same medicine, tirzepatide, but they are separate products with their own FDA labels, approved uses and doses, and they are not interchangeable. Mounjaro: Type 2 diabetes (age 10+); cardiovascular risk reduction. Zepbound: Chronic weight management; obstructive sleep apnea in obesity.